Basic HTML Version
International Journal of Molecular Medical Science
16
Umetsu S.E., and Winandy S., 2009, Ikaros is a regulator of
Il10 expression in CD4
+
T cells, J. Immunol., 183(9):
5518-5525
http://dx.doi.org/10.4049/jimmunol.0901284
PMid:19828627 PMCid:PMC2778601
Vig R., Mao C., Venkatachalam T.K., Tuel-Ahlgren L.,
Sudbeck E.A., and Uckun F.M., 1998, Rational design and
synthesis of
phenethyl-5-bromopyridyl
thiourea
derivatives as potent non-nucleoside inhibitors of HIV
reserve transcriptase, Bioorg Med Chem., 6(10):
1789-1797
http://dx.doi.org/10.1016/S0968-0896(98)00108-4
Walker J.R., Corpina R.A., and Goldberg J., 2001, Structure of
the Ku heterodimer bound to DNA and its implications
for double-strand break repair, Nature, 412: 607-614
http://dx.doi.org/10.1038/35088000 PMid:11493912
Yap W.H., Yeoh E., Tay A., Brenner S., and Venkatesh B., 2005,
STAT4 is a target of the hematopoietic zinc-finger
transcription factor Ikaros in T cells, FEBS Lett., 579(20):
4470-4478
http://dx.doi.org/10.1016/j.febslet.2005.07.018
PMid:16081070
Yoshida T., Ng S.Y., and Georgopoulos K., 2010, Awakening
lineage potential by Ikaros-mediated transcriptional
priming, Curr. Opin. Immunol., 22(2): 154-160
http://dx.doi.org/10.1016/j.coi.2010.02.011
PMid:20299195
Yu S., Asa S.L., and Ezzat S., 2002, Fibroblast growth factor
receptor 4 is a target for the zincfinger transcription factor
Ikaros in the pituitary, Mol. Endocrinol., 16(5): 1069-1078
http://dx.doi.org/10.1210/me.16.5.1069 PMid:11981041
Zhang J., Jackson A.F., Naito T., Dose M., Seavitt J., Liu F.,
Heller E.J., Kashiwagi M., Yoshida T., Gounari F., Petrie
H.T., and Georgopoulos K., 2011, Harnessing of the
nucleosome-remodelingdeacetylase complex controls
lymphocyte development and prevents leukemogenesis,
Nat. Immunol., 13(1): 86-94
http://dx.doi.org/10.1038/ni.2150 PMid:22080921
Molecular Medical Science, Int’l Journal of